Nuventra Pharma Sciences is now Allucent. Learn more here.

Strategic guidance from
proven professionals

Nuggehally Srinivas (Srini), Ph.D.

Vice President, Clinical Pharmacology

Nuggehally Srinivas (Srini), Ph.D., has 30 years of extensive experience in pre-clinical and clinical drug development with expertise in clinical pharmacology, ADME, PKPD, regulatory and biopharmaceutics/drug delivery. He has used ADME strategy for clinical candidate nomination during drug discovery-development transition. In the past, Dr. Srinivas worked for Jubilant Life Sciences, Cadilla Healthcare, Eli Lilly’s JV company, Dr. Reddy’s and Bristol-Myers Squibb. His therapeutic area experience includes: metabolic disorders, oncology, neurosciences, cardiovascular, immunology, inflammation, and anti-infective. He has experience with product differentiation strategies and seamless development using a 505(b)(2) approach and has interacted with multiple regulatory agencies including: FDA, HPB/TPD, EMEA, MHRA, MCC, TGA, and DCGI.

Education

  • Doctor of Philosophy, Pharmacokinetics and Pharmacodynamics
    • University of Saskatchewan, Saskatoon, Saskatchewan
  • Bachelor of Science, Pharmacy
    • Bangalore University, Bengaluru, India